AstraZeneca Covid-19 vaccine shows 74% efficacy in US trial

Overall efficacy of 74% was lower than the interim 79% figure reported by the British drugmaker in March, a result AstraZeneca revised days later to 76% after a rare public rebuke from health officials

Related Keywords

United Kingdom , Peru , Chile , United States , British , Pascal Soriot , Anna Durbin , Johns Hopkins University , Astrazeneca , Astrazeneca Plc Covid , Drug Administration , Oxford University , Astrazeneca Plc , New England Journal , Executive Pascal Soriot , Astrazeneca Covid 19 Vaccine , Strazeneca Covid 19 Vaccine Us , Strazeneca Covid 19 Vaccine Trials , Strazeneca Covid 19 Vaccine Trials In Us , Strazeneca Covid 19 Vaccine Us Trials , Pfizer , Biontech , Moderna , Pfizer Biontech Covid 19 Vaccine , Moderna Covid 19 Vaccine ,